Brachytherapy Market by 2026 | Major Players Elekta, Theragenics Corporation, Sun Nuclear Corporation, Argon Medical Devices, Eckert & Ziegler BEBIG

Rising number of prostate cancer cases are majorly driving growth of the brachytherapy market. According to the American Cancer Society, as of 2017, around 161,370 people are estimated to be diagnosed with prostate cancer and around 26,730 deaths are recorded due to prostate cancer in the U.S. Prostate cancer is the third-leading cause of death for men in the U.S. The other factors that are contributing to growth of the brachytherapy market include, rising adoption of high dose rate brachytherapy and increasing prevalence of obesity. However, side effects associated with radiation therapy such as hair loss, fatigue, appetite, and nausea are expected to hinder growth of the brachytherapy market.

Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/1952

Key players involved in the brachytherapy market include Elekta, Theragenics Corporation, Sun Nuclear Corporation, Argon Medical Devices, Eckert & Ziegler BEBIG, and IsoRay Medical. The key players are focusing on strategic mergers and acquisitions and development of innovative products. For instance, IsoRay Inc. in 2016, announced the launch of a pilot study using intraoperative placement of cesium-131 permanent interstitial brachytherapy in high risk recurrent head and neck cancer.

According to the Centers for Disease Control and Prevention, in 2014, around 236,968 women and 2,141 men were diagnosed with breast cancer in the U.S. Furthermore, Asia Pacific is expected to be the key region in the global brachytherapy market, owing to the launch of Esteya Machine in 2016, for skin cancer treatment. The treatment uses low energy x-rays to target the cancerous site, with the ability to treat multiple lesions at once and a reduced chance of scarring.

The approach of targeting cancerous cells by brachytherapy reduces the risk of any damage to healthy tissues and organs surrounding the tumor, thereby reducing the potential side effects as well. Brachytherapy is used in the treatment for prostate, cervix, breast, and skin cancers and can also be used to treat tumors in other sites of the body such as the head and neck. Moreover, it is often used in combination with chemotherapy drugs to decrease the risk of recurring cancer. Brachytherapy are of two different types namely, permanent and temporary.

Request Sample Copy Of This Report: www.coherentmarketinsights.com/insight/request-sample/1952

Market Taxonomy:

The global brachytherapy market is segmented on the basis of type, application, and geography

On the basis of dose type, the global brachytherapy market is segmented into:

High Dose Rate Brachytherapy
Low Dose Rate Brachytherapy
On the basis of application, the global brachytherapy market is segmented into:

Prostate Cancer
Breast Cancer
Gynecological Cancer
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.